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Abstract Post-coital intravaginal cleansing (IVC) could
counteract the protective effect of a vaginal microbicide.
IVC less than 1 h after sex is discouraged in most micro-
bicide trials. During a microbicide trial in KwaZulu-Natal,
we collected quantitative data on post-coital IVC. We
discussed IVC during in-depth-interviews (IDIs) and focus-
group discussions (FGDs) with women enrolled in the trial,
and during FGDs with community members. Nearly one-
third (336/1,143) of women reported IVC less than an hour
after sex. In multivariate analysis, post-coital IVC was
associated with younger age, larger household size, greater
sexual activity, consistent gel use, and clinic of enrolment.
During IDIs and FGDs, respondents described post-coital
IVC as a common hygiene practice motivated by the need
to remove semen, vaginal fluids and sweat, although this
practice may be amenable to change in the context of
microbicide use. We need to consider strategies for
influencing post-coital IVC practices in future microbicide
trials and delivery programmes.
Keywords Microbicides  Acceptability  Adherence 
Post-coital intravaginal cleansing  South Africa
Introduction
In 2010, the CAPRISA 004 trial provided proof for the
concept of vaginal microbicides [1]. The trial demonstrated
a 39 % reduction in the risk of HIV acquisition among
women assigned to use tenofovir microbicide gel before
and after sex when compared to placebo gel. If the FACTS
001 confirmatory trial supports these results [2], vaginal
microbicides may well be introduced as an additional HIV
prevention option for women in South Africa. A number of
behavioural factors are likely to influence the effectiveness
of microbicides. The primary factor is whether women use
microbicides when expected [3]. However, an additional
factor is whether women use microbicides as expected. In
International Standard Randomised Controlled Trial Registry
(ISRCTN64716212).
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microbicide trials to date, women have usually been
advised to insert a microbicide gel either before sex, or
before and after sex, and to refrain from intravaginal
cleansing for at least an hour after sex. This is due to
concerns that post-coital intravaginal cleansing could
remove the microbicide too soon after male ejaculation and
counteract the protective effect of the microbicide [4].
The World Health Organisation define intravaginal
cleansing as internal cleansing or washing inside the vagina
which includes wiping the internal genitalia with fingers
and other substances (e.g., cotton, cloths, paper) for the
purpose of removing fluids. It also includes douching,
which is the pressurised shooting or pumping of water or
solution (including douching gel) into the vagina [5]. There
has been extensive research into women’s intravaginal
cleansing practices in sub-Saharan Africa. In South Africa,
studies in the general population have found that the per-
centage of women reporting intravaginal cleansing varies
considerably, from 13 % in the Western Cape to 87 % in
Gauteng [5–14], although the prevalence was higher
among commercial sex workers [15–18]. Intravaginal
cleansing is practiced for a variety of reasons such as
maintaining vaginal hygiene and health, treating infections,
and preparing for sex [5]. The reasons for the practice
influence the timing, frequency and type of cleansing
performed [5, 11, 19, 20]. The main concern for microbi-
cide effectiveness relates to post-coital intravaginal
cleansing within the first hour after sex.
Only two studies have reported on post-coital intrava-
ginal cleansing in South Africa; one study reported a
prevalence of 9 % and the other 19 % [11, 21]. Although
neither of these studies reported on how long after sex
intravaginal cleansing was performed, one study in Tan-
zania found that half the women who intravaginally
cleansed after sex, did so within 2 h [22]. While a number
of microbicide trials have reported the prevalence of in-
travaginal cleansing at baseline, ranging from 25 to 100 %
[23–27], only two specifically measured intravaginal
cleansing in relation to sexual activity and only one of
these reported on it during follow-up. In the HPTN 035
study, at baseline around a quarter of women reported in-
travaginal cleansing before sex and a similar percentage
after sex [28]. In the Cellulose Sulphate trial in Nigeria,
nearly three quarters of women reported intravaginal
cleansing after sex at baseline but this fell to 6 % during
follow-up [29]. There are still gaps in our understanding of
post-coital intravaginal cleansing practices and the use of
vaginal microbicides [30].
In this paper, we use quantitative and qualitative data
collected as part of the Microbicides Development Pro-
gramme (MDP) 301 clinical trial in KwaZulu-Natal, South
Africa to examine post-coital intravaginal cleansing during
a microbicide trial. Using quantitative data, we investigate
patterns of post-coital intravaginal cleansing during the
course of the trial and characterize women who practice
intravaginal cleansing less than an hour after sex. Using
qualitative data, we examine socio-cultural norms relating
to intravaginal cleansing and explore intravaginal cleansing
practices among women using microbicide gels. We then
consider the implications of post-coital intravaginal
cleansing practices for the introduction of microbicides in a
rural part of KwaZulu-Natal, South Africa.
Methods
Quantitative Methods
Cohort
The Africa Centre for Health and Population Studies [31]
was one of six research centres conducting the MDP 301
randomised, double-blind, placebo-controlled, phase III
clinical trial that evaluated the safety and efficacy of
PRO2000 microbicide gel in the prevention of vaginally-
acquired HIV infection [32–34]. In total, 1,177 women
enrolled in the Africa Centre MDP 301 trial in KwaZulu-
Natal from March 2006 to August 2008 with follow-up
visits continuing until August 2009. We excluded from the
analyses 34 women who did not provide data on intrava-
ginal cleansing, including a total of 1,143 women who
provided data on intravaginal cleansing.
We enrolled and followed up women at three research
clinics: clinic one was located in a township, clinic two was
Table 1 Demographics of IDI respondents
Trial IDIs
No of trial participants 84
No of IDIs 214
Mean age (range) 34 (19–64)
Employed 19 %
Marrieda 24 %
Secondary school education or above 54 %
Rural residencyb 77 %
Partner as head of household 39 %
Consistent gel user 57 %
Consistent condom user 40 %
Clinic of recruitment
Clinic 1 32 %
Clinic 2 39 %
Clinic 3 29 %
a Marital status was ascertained from the IDI narratives
b Residency missing for one women; one urban resident, remainder
peri-urban
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located in a small town, and clinic three was located in a
rural area under tribal authority. All three clinics recruited
women from rural areas in addition to the immediate locale
of the clinic. At enrolment, women were randomized to use
2 % PRO2000, 0.5 % PRO2000 or placebo gel until Feb-
ruary 2008 when evaluation of 2 % PRO2000 was dis-
continued due to futility, after which time women were
randomised to use 0.5 % PRO2000 or placebo gel [35]. We
counselled women to insert a pre-filled applicator of gel no
more than 1 h before each sex act, and to refrain from
intravaginal cleansing for at least 1 h after sex.
Dependent Variable
Counsellors administered sexual behaviour questionnaires
at clinic visits 4, 24, 40 and 52 weeks after enrolment. We
collected data about each sex act in the last week, or the
last 4 weeks if a woman had not had sex in the last week.
For each sex act, we asked women the following question:
‘‘Did you clean inside your vagina after sex?’’ Staff clari-
fied that intravaginal cleansing included any form of
cleansing inside the vagina including the use of water,
fingers or a dry cloth. Based on the investigators’ brochure,
participants were advised not to intravaginally cleanse for
up to an hour after sex as this may counteract the protective
effect of the microbicide. As such, we asked women who
reported cleansing inside their vagina after sex, how long
after sex they had cleansed. Although we were interested in
capturing data on post-coital cleansing within 1 h of sex,
we asked about additional time periods to further under-
stand local practices. We recorded responses as either less
than 1 h, between 1 and 2 h, or more than 2 h after sex.
The outcome measure for this analysis is cleansing inside
the vagina less than 1 h after sex at any time during the
trial.
Independent Variables
Baseline independent variables considered in this analysis
included age, highest educational level attained, employ-
ment status, area of residency, religion, use of reliable
contraception (injectable, oral pill, sterilised), relationship
to the head of the household (as a proxy for cohabitation if
the woman reported her partner as the household head,
although cohabitation cannot be ruled out in other head of
household relationships), and household size (measured
using the number of adults who usually sleep in the
household divided by the number of rooms usually used for
sleeping). We also considered longitudinal behavioural
variables including consistent gel and consistent condom
use throughout the trial, average sexual frequency, dis-
cussing gel use with a partner, sex during menstruation or
multiple partners at any time during the 12 month follow
up period. We assessed associations with clinical outcomes
based on the results of HIV, pregnancy, gonorrhoea,
chlamydia, Trichomonas vaginalis and syphilis testing
conducted during the trial. We also considered clinic of
enrolment and gel randomisation group.
Quantitative Analysis
We compared women who reported intravaginal cleansing
(IVC) less than 1 h after sex at some time during the trial to
those who did not. We also considered changes over time
in intravaginal cleansing less than 1 h after sex by com-
paring the proportions of women who intravaginally
cleansed in the first 6 months of the trial to the proportion
in the last 6 months of the trial. We assessed univariate
associations with intravaginal cleansing using the Pearson
Chi2 test. We tested the contribution to the multivariable
model of each variable that was significant in univariate
analysis at the 0.10 level using likelihood ratio tests (LRT)
[36]. We assessed multivariate associations at the 0.05
level, after controlling for potential confounding factors,
through multiple logistic regression analyses. Data were
analysed using Stata 10 (StataCorp, College Station, Texas,
USA).
Qualitative Methods
Cohort
At enrolment, 101 trial participants were randomly selected
to participate in in-depth interviews (IDIs). Each woman
randomly selected for IDIs was invited to interview three
times during the trial, at 4, 24 and 52 weeks after enrol-
ment, in order to capture women’s experiences at the
beginning, middle and end of follow-up. Of these, 12
women refused to participate mainly due to the time
commitment, one woman withdrew from the trial before
the first interview, and four were never available for
interview. Consequently, a total of 84 women participated
in interviews. Ten women were interviewed once, 18 were
interviewed twice, and 56 were interviewed three times for
Table 2 Demographics of FGD respondents
Trial
FGDs
Community
FGDs (female)
Community
FGDs (male)
No of people 77 54 103
No of FGDs 10 6 11
Mean age (range) 36 (19–65) 37 (21–63) 30 (17–67)
Employeda 21 % 13 % 5 %
Marrieda 27 % 41 % 14 %
a Employment and marital status were collected in all but two of the
trial FGDs
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a total of 214 interviews with these 84 women. The
interview guide included the following topics: study
acceptability and comprehension, gel acceptability, gel and
condom use, partnership types and involvement in gel use,
risk perception, sexual practices, and vaginal practices
including cleansing and insertion. Women who reported
washing inside their vagina after sex, were asked how long
after sex they had washed. Data included in this paper
relate to washing within approximately an hour after sex.
We invited trial participants not randomly selected for
IDIs, to participate in focus group discussions (FGDs) on
an ad hoc basis. We advertised FGDs at the MDP clinics
and stratified them by age and clinic of enrolment. During
the course of the trial 10 standard FGDs were conducted
with an average of nine women per group, ranging from
five to 20 women. A total of 77 trial participants took part
in the 10 FGDs. The FGD guide for trial participants
included the same topics as the trial IDI guide.
We also advertised FGDs at community events and
conducted them with women and men who were resident in
the trial catchment area but not enrolled in the trial.
Community FGDs were stratified by sex, age and area of
residence. During the course of the trial 17 standard FGDs
were conducted with community members with an average
of nine women or men per group ranging from 5–13. In
total six FGDs were conducted with 54 women and 11
FGDs were conducted with 103 men. The topics discussed
in the community FGDs were the MDP trial, theoretical gel
acceptability, partner involvement in gel use, sexual prac-
tices and vaginal practices including cleansing and
insertion.
Demographics of the IDI and FGD respondents are
shown in Tables 1 and 2. In the qualitative results section,
we refer to the trial participants as well as women and men
from the community who took part in the IDIs and FGDs,
as respondents to avoid confusion with specific participants
enrolled in the trial.
Qualitative Analysis
We conducted IDIs and FGDs in isiZulu. They were audio
recorded, transcribed, translated into English, and imported
into NVivo 2, later NVivo 8, for coding (NVivo qualitative
data analysis software; QSR International Pty Ltd. Version
2, 2002; Version 8, 2008). The majority of transcripts
included both the isiZulu transcription and English trans-
lation, although only the English translation was available
for 51 IDIs and eight FGDs when direct audio-translation
was used with additional quality control of the translated
text. Coding was conducted in English. The credibility and
trustworthiness of interpretations were considered
throughout the trial by presenting results of sub-analyses to
local staff and members of the community and participant
advisory boards.
We conducted thematic analysis in two stages. Firstly,
we analysed the 17 community FGDs and 10 trial partici-
pant FGDs, coding all text that addressed issues relating to
intravaginal cleansing immediately after sex. Two main
themes emerged from the data: classification of, and
motivation for intravaginal cleansing. Secondly, we ana-
lysed data from the 214 in-depth interviews, again coding
all text that addressed issues relating to intravaginal
cleansing immediately after sex. Three main themes
emerged from the data: intravaginal cleansing practices
generally, intravaginal cleansing in relation to gel use, and
intravaginal cleansing in relation to sex during
menstruation.
Participants provided written informed consent for trial
enrolment. In addition, trial participants and community
members provided written informed consent for participa-
tion in IDIs and FGDs. The University of KwaZulu-Natal
Biomedical Ethics Committee (T111/05) and the South
African Medicine Controls Council (N2/19/8/2) reviewed
and approved the trial protocol.
Results
Quantitative Analysis
Of the 1,143 women included in the analysis, 336 (29 %)
reported cleansing inside their vagina less than 1 h after
sex at some point during the trial [464 (41 %) reported
cleansing inside their vagina at any time after sex]. Women
who intravaginally cleansed less than 1 h after sex were
younger than women who did not (mean age 33 vs.
35 years, t test p value 0.020) and there was a linear cor-
relation with age (OR 0.99; p-value 0.021).
As shown in Table 3, post-coital intravaginal cleansing
less than 1 h after sex was associated at the 10 % level with
age group, living in a rural area, living in a large house-
hold, consistent gel use, consistent condom use, discussing
gel with a partner, having multiple sex partners, enrolling
in the trial in clinics 2 or 3, and having more frequent sex.
In terms of sexual frequency, women reported a mean of
4.8 sex acts a week on average during the trial (range 1–
15.5, SD 2.09) and there was a linear correlation between
post-coital intravaginal cleansing and sexual frequency
after adjusting for age (AOR 1.11; p-value 0.001). Intrav-
aginal cleansing practices did not differ by gel randomi-
sation group (p = 0.189). We excluded consistency of
condom use from the multivariate model, as this variable
did not contribute to the model in likelihood ratio tests
(LRT p-value 0.526).
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Table 3 Characteristics of women who did and did not intravaginally cleanse less than 1 h after sex
Characteristics Total sample
N (col %)
Did not intravaginally
cleanse less than 1 h
after sex n (row %)
Intravaginally cleansed
less than 1 h after
sex n (row %)
Chi2
p-value
1,143 (100 %) 807 (71 %) 336 (29 %)
Age group 0.084
18–24 326 (29 %) 216 (66 %) 110 (34 %)
25–34 243 (21 %) 175 (72 %) 68 (28 %)
35–44 274 (24 %) 190 (69 %) 84 (31 %)
45? 300 (26 %) 226 (75 %) 74 (25 %)
Educational level 0.453
Primary or lower 557 (49 %) 398 (71 %) 159 (29 %)
Incomplete secondary 367 (32 %) 262 (71 %) 105 (29 %)
Complete secondary 219 (19 %) 147 (67 %) 72 (33 %)
Employment status 0.644
Unemployed 948 (83 %) 672 (71 %) 276 (29 %)
Employed 195 (17 %) 135 (69 %) 60 (31 %)
Area of residency 0.008
Rural 899 (79 %) 618 (69 %) 281 (31 %)
Peri-urban/urban 244 (21 %) 189 (77 %) 55 (23 %)
Religion 0.312
Christian 250 (22 %) 181 (72 %) 69 (28 %)
Zionist 528 (46 %) 369 (70 %) 159 (30 %)
Shembe 279 (24 %) 190 (68 %) 89 (32 %)
None/other 86 (8 %) 67 (78 %) 19 (22 %)
Household size 0.008
3 people or more 632 (55 %) 426 (67 %) 206 (33 %)
1–2 people per room 511 (45 %) 381 (75 %) 130 (25 %)
Relationship to household head 0.351
Partner 484 (42 %) 351 (73 %) 133 (27 %)
Parent 394 (35 %) 265 (67 %) 129 (33 %)
Self 123 (11 %) 88 (72 %) 35 (28 %)
Other 142 (12 %) 103 (73 %) 39 (27 %)
Contraceptive use 0.461
No 567 (50 %) 406 (72 %) 161 (28 %)
Yes 576 (50 %) 401 (70 %) 175 (30 %)
Gel use 0.031
Sometimes/never 436 (38 %) 324 (74 %) 112 (26 %)
Always 707 (62 %) 483 (68 %) 224 (32 %)
Condom use 0.083
Always 494 (43 %) 340 (69 %) 154 (31 %)
Sometimes 426 (37 %) 296 (69 %) 130 (31 %)
Never 223 (20 %) 171 (77 %) 52 (23 %)
Discuss gel with partner 0.042
Yes 939 (82 %) 651 (69 %) 288 (31 %)
No 204 (18 %) 156 (76 %) 48 (24 %)
Average no. of sex acts \0.001
1 to 5 acts 872 (76 %) 646 (74 %) 226 (26 %)
6 ? acts 271 (24 %) 161 (59 %) 110 (41 %)
Multiple partners 0.065
No 1,022 (89 %) 717 (70 %) 305 (30 %)
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Although we did not collect data on marital status or
cohabitation, the vast majority (99 %) of women reported
being in stable, long-term relationships. As a proxy for
cohabitation, we compared intravaginal cleansing practices
based on a woman’s relationship to the head of the
household and found no statistically significant differences
(p = 0.351).
We compared post-coital intravaginal cleansing among
women who had HIV seroconverted, become pregnant, or
been diagnosed with gonorrhoea, chlamydia, Trichomonas
vaginalis or syphilis during the trial, to those who had not
(data not presented due to space but available from authors
on request). Intravaginal cleansing was not associated with
receiving a diagnosis of HIV, chlamydia, Trichomonas
vaginalis or syphilis. A higher proportion of women diag-
nosed with gonorrhoea reported post-coital intravaginal
cleansing (42 % p = 0.021), while a lower proportion of
women who became pregnant during the course of the
study reported post-coital intravaginal cleansing (19 %
p = 0.041). However, neither gonorrhoea (LRT p-value
0.113) nor pregnancy (LRT p-value 0.153) contributed to
the model in likelihood ratio tests so they were not included
in the multivariate model.
We did not collect data relating specifically to post-
coital intravaginal cleansing around the time of menstrua-
tion. Seventy (6 %) women reported having sex during
menstruation at some time during the trial, but this was not
associated with post-coital intravaginal cleansing
(p = 0.700). Eighty-seven percent (61/70) of these women
reported typically using gel when having sex during
menstruation.
Table 4 presents the output from the final multivariate
model. In the multivariate model, women who intravagin-
ally cleansed less than 1 h after sex were more likely to
live in larger households, consistently use gel, report
greater sexual activity and were more likely to have
enrolled at the clinics in the town (clinic 2) or the tribal
authority area (clinic 3). Women aged 45 years or older
were less likely to cleanse intravaginally after sex.
Since post-coital intravaginal cleansing would only
affect the risk of HIV infection in the absence of condom
use, we repeated the multivariate analysis after excluding
sex acts where women reported using a condom. In this
analysis, 22 % (249/1143) of women reported intravagin-
ally cleansing less than 1 h after a sex act in which they did
Table 3 continued
Characteristics Total sample
N (col %)
Did not intravaginally
cleanse less than 1 h
after sex n (row %)
Intravaginally cleansed
less than 1 h after
sex n (row %)
Chi2
p-value
Yes 14 (1 %) 7 (50 %) 7 (50 %)
Missing 107 (9 %) 83 (78 %) 24 (22 %)
Clinic of enrolment \0.001
Clinic 1 438 (38 %) 369 (84 %) 69 (16 %)
Clinic 2 369 (32 %) 239 (65 %) 130 (35 %)
Clinic 3 336 (30 %) 199 (59 %) 137 (41 %)
Table 4 Multivariate model comparing women who did and did not
intravaginally cleanse less than 1 h after sex
Adjusted OR 95 % CI P value
Age group
18–24 1.00
25–34 0.74 0.50, 1.09 0.124
35–44 0.75 0.52, 1.09 0.130
45? 0.59 0.41, 0.87 0.007
Household size
3 people or more 1.00
1–2 people per room 0.73 0.56, 0.96 0.026
Residency
Rural 1.00
Peri-urban/urban 1.10 0.76, 1.63 0.594
Clinic of enrolment
Clinic 1 1.00
Clinic 2 3.02 2.12, 4.30 \0.001
Clinic 3 3.63 2.47, 5.33 \0.001
Multiple partners
No 1.00
Yes 3.01 0.98, 9.21 0.054
Missing 0.65 0.39, 1.08 0.097
Gel use
Sometimes/never 1.00
Always 1.50 1.12, 2.00 0.006
Discussed gel with partner
Yes 1.00
No 0.71 0.49, 1.03 0.069
Average number of sex acts
1 to 5 acts 1.00
6 ? acts 1.48 1.09, 2.01 0.011
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not use a condom. In general, the association between post-
coital IVC and the independent variables seen in Table 4
did not change in the re-analysis. However, in the multi-
variate model the odds of intravaginal cleansing were
significantly lower among women aged 25–34 (AOR 0.55,
95 % CI 0.36, 0.83) and 35–44 years old (AOR 0.52, 95 %
CI 0.35, 0.78). Unlike in the earlier model, the associations
between post-coital intravaginal cleansing and reporting
multiple partners or discussing gel use with the partner
were statistically significant (multiple partners AOR 3.68,
95 % CI 1.20, 11.34; discussed gel with partner AOR 0.60,
95 % CI 0.39, 0.92). On the other hand, the association
with household size was no longer significant (AOR 0.81,
95 % CI 0.60, 1.10).
Of the 1,143 women included in our analysis, 1,065
provided data on intravaginal cleansing practices in both
the first and second half of the trial. In the first half of the
trial, from week 4 to week 24, 277 (26 %) women reported
intravaginal cleansing less than 1 h after sex. In the second
half of the trial, from week 28 to week 52, this had fallen to
138 (13 %). One hundred and ninety-eight (198) women
reported intravaginal cleansing in the first half of the trial
but not the second half. The only independent association
with decreased cleansing was clinic of enrolment. With
clinic one as the reference, women in clinic two were twice
as likely to stop cleansing (OR 2.27; CI 1.51, 3.41) and
women in clinic three were almost 3 times more likely to
stop cleansing (OR 2.73; CI 1.82, 4.10) (data not presented
due to space but available from authors on request).
Qualitative FGD Analysis
Classification
Respondents agreed that intravaginal cleansing was a reg-
ular part of women’s general daily hygiene routine. In
terms of vaginal cleansing after sex, respondents agreed
that women used one of two practices, either external or
internal cleansing. There were examples of both classifi-
cation types provided in every FGD.
Approximately two-thirds of FGD respondents said
women wiped outside their vagina after sex. Women
reportedly wiped with a dry or damp cloth, towel, tissue or
toilet paper. Some respondents even said that many women
had a specific towel for this purpose that they kept at the
head of their bed. This quote exemplifies a common theme
regarding different cleansing practices (wiping externally
versus washing internally) depending on whether a woman
had sex in the day or in the night:
‘‘If you have sex during the day you wash because
you still have to go outside, so you cannot wipe with
a towel. (At night) you wipe because you are going to
sleep and you wash in the morning’’ (Community
FGD, exact age unknown but one of seven respon-
dents aged between 22 and 32 years old).
Approximately a third of FGD respondents said women
washed inside their vagina after sex, even during the night.
The respondents explained that women would usually get up
after sex to go and wash. This was described as occurring
immediately after sex, so within approximately an hour of sex.
There were also frequent reports of women placing a basin of
water next to the bed at night in order to wash after sex:
‘‘I do not know what the other people do but with me
I put my water next to me when I sleep so that
immediately after sex I take it and wash myself
because I hate the sperm’’ (Community FGD, 35-
year-old woman).
Intravaginal cleansing involved the insertion of either
cloth or fingers. Respondents described the use of fingers to
clean intravaginally after sex in 4 out of 10 FGDs with trial
participants and 2 out of 6 community FGDs with women.
However, no one mentioned finger cleansing in any of the
11 community FGDs with men, suggesting that women
practice this privately. In the majority of cases, intravaginal
cleansing also included the use of water. Respondents
reported that women used plain, usually cold, water. Only a
few women and men mentioned the use of disinfectants
(liquid Dettol or Savlon) in the water.
Motivation
Many women described the vagina as requiring specific
cleaning because, as this woman explained:
‘‘We were given a smelly piece of organ’’ (Com-
munity FGD, 59-year-old woman).
Respondents also described semen as being dirty and
smelly. The combination of semen, vaginal discharge and
sweat required that women clean themselves after sex.
Respondents described the need to remove the smell of
sexual fluids as a necessary part of having self-respect. One
woman explained that women wash after sex ‘‘if one is a
woman who loves herself’’ but also explained that:
‘‘There are women who do not love themselves: she
does not wash after sex even during the day. She
would have a bad smell because sperm or discharge
keeps on coming out’’ (Community FGD, 31-year-old
woman).
Similarly, respondents frequently described intravaginal
cleansing as a necessary part of respecting your partner and
others in the household:
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‘‘The expectation is that the woman brings water in
her bedroom so that she washes (intravaginally) first
before meeting people and making tea for them’’
(Community FGD, 59 year old woman).
However, half a dozen respondents, a mix of female and
male, suggested that it could be a sign of disrespect to a
man for a woman to wash after sex:
‘‘Some men will say don’t wash because it will lower
their dignity’’ (Community FGD, 19 year old man).
Except for men’s lack of knowledge of finger cleansing,
there were no obvious distinctions in opinion between
women and men regarding how, when or why women in-
travaginally cleansed after sex. Women knew more than
men about vaginal cleansing practices, but this was
expected. Similarly, there were no obvious differences
between group discussions with younger versus older
people, or rural versus peri-urban respondents. There was
clear agreement that it was necessary to clean after sex in
order to remove both female and male sexual fluids.
There were a few unprompted conversations about the
health implications and health benefits of intravaginal
cleansing. In a community FGD, one woman stated that it
was not necessary to wash after sex as women were not
advised to do so at the primary health care centres.
Respondents mentioned the idea of washing after sex to
reduce the risk of HIV in 4 out of 11 community FGDs
with men and 1 out of 6 community FGDs with women, but
none with trial participants. Men raised this issue more
than women, probably because the benefits of washing
after sex were viewed as more pertinent to men, as this
FGD exchange demonstrates:
‘‘I heard another sister saying that after sex it is
important to wash but using moving water like in the
shower because if one does not wash after sex one
might get HIV infection but washing immediately
after sex helps to avoid HIV infection’’(Community
FGD, 26 year old woman).
‘‘I heard that but I do not believe it. Maybe it is better
for men but the (female) abdominal structure allows
things to enter inside, so even washing will not help
me’’ (Community FGD, 30 year old woman).
It was noteworthy that only one focus group discussed
condom use in the context of intravaginal cleansing and
stated that using a condom did not reduce the need to
cleanse intravaginally.
Qualitative IDI Analysis
In the in-depth interviews, women agreed that it was
common to either wipe outside the vagina or wash inside
the vagina immediately after sex. The motivations pro-
vided for intravaginal cleansing in the IDIs, mirrored those
provided in the FGDs.
Intravaginal Cleansing Among Trial Participants
During the IDIs, women’s comprehension of many of the
key trial messages was assessed—for example their
understanding that the gel was investigational and that the
gel could not be used when pregnant. However, we did not
assess their understanding of the message not to intrava-
ginally cleanse less than 1 h after sex thoroughly in the
interviews. It was obvious that some women clearly
understood this requirement, but often it was not clear
whether women who continued to cleanse intravaginally
less than 1 h after sex understood that this could potentially
limit the effectiveness of a microbicide gel.
Of the 84 women interviewed, 33 reported intravagin-
ally cleansing immediately after sex in at least one in-depth
interview, although reports were highest at the week 4
interview declining by the week 24 and 52 interviews.
Some women reported just using water to wash internally.
However, no one reported using a douching device of any
sort so it was not clear from the interviews how exactly
women inserted water. A few women reported using soapy
water, specifically referring to the use of ‘Sunlight’, which
is a popular soap brand in South Africa. Some women
reported just using face cloths or towels to clean intrava-
ginally, usually dampened. Approximately half of the
women reported inserting either a single finger or multiple
fingers in order to clean inside the vagina after sex. Some
reported just using their fingers to clean while other women
reported using a cloth over the fingers:
‘‘It is the towel which gets inside together with the
finger too, though the finger is in the towel’’ (Trial
IDI, 39-year-old woman).
In the IDIs, respondents regularly mentioned the impact
of condom use on intravaginal cleansing. For the majority,
the use of a condom did not alter their need to cleanse after
sex as they still found it necessary to remove their own
vaginal fluids. However, a few women reported that they
were less inclined to cleanse intravaginally after sex if their
partners had worn condoms:
‘‘Before I started using condoms I used to wash…..-
Now there is no dirtiness because I am using con-
doms’’ (Trial IDI, 46 year old woman).
Microbicide Gel Use
Two women thought that they were supposed to clean after
sex in order to remove the gel. Despite counselling not to
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intravaginally cleanse less than an hour after sex, some
women continued to do so, as it was their usual practice.
This woman refers to her ‘sperm’, which is a term com-
monly used to refer to female sexual fluids, as well as male,
in this community:
‘‘I like cleaning myself, so as to remove gel and my
sperms (ama-sperms), because it’s not easy for his
dirt to get into me because we would have used a
condom. I just wash to clean my dirt’’ (Trial IDI, 39-
year-old woman).
Other women specifically cleansed intravaginally
between sex acts. This woman was asked why she intrav-
aginally cleansed between sex:
‘‘To remove the old gel because it will not work…. I
insert fingers, wipe with a towel, and insert the
gel….After we had sex I wash to remove the old gel
because I don’t want him to want sex again before I
have inserted the gel again’’ (Trial IDI, 46 year old
woman).
Approximately half a dozen women explained that they
used to wash intravaginally after sex, but since joining the
trial and receiving counselling not to, no longer wash in-
travaginally if they used gel:
‘‘I know that I should wash after having sex, but if I
used the gel I don’t wash because it was said that I
shouldn’t wash (internally), I should wipe (exter-
nally)’’ (Trial IDI, 26 year old woman).
Interestingly there were no reports of women merely
delaying intravaginal cleansing for more than an hour after
sex based on counselling from the research staff not to
cleanse within an hour. There were no suggestions of why
some women continued to intravaginally cleanse immedi-
ately after sex when using gel and others did not, except for
women’s individual attitudes to, and preference for, post-
coital cleansing.
Sex During Menstruation
Most respondents believed that sex during menstruation
was rare, describing it as culturally and religiously unac-
ceptable. In the IDIs, sex during menstruation was descri-
bed as dirty (ngcolile), smelly (nuka), shameful
(amahloni), disgraceful or disgusting (ihlazo), embarrass-
ing (ukuhlaziswa) and as a sign of a lack of self-respect
(ukuzenyanya – does not love oneself). Indeed, the
Shembe1 religion [37], which was the second largest
religion, expressly forbids women to have any contact with
men during menses, as this quote illustrates:
‘‘I don’t prepare him food when I am menstruating.
Food for him is prepared by the children, I don’t even
sleep in his bedroom, I leave his bedroom’’ (Trial
IDI, 48-year-old woman).
Nonetheless, respondents suggested that women were
more likely to cleanse intravaginally after sex during
menstruation. In fact, a number of women reported that
they only intravaginally cleansed after sex if they have sex
whilst menstruating:
‘‘You can usually wash only when you have been
doing sex whilst menstruating, then you could maybe
wash because of that reason’’ (Trial IDI, 33-year-old
woman).
Having sex during menstruation was most frequently
attributed to labour migration, whereby if the couple were
only together for a short period of time when a migrant
labourer was home and the women was menstruating the
whole time, then they would not forego sex. Some
respondents believed that the body was weak during
menstruation and therefore more prone to infection during
sex. Despite the objections to sex during menstruation, 14
of the 84 women reported having sex during menstruation
while in the trial. Over half reported typically using gel
when having sex during menstruation, and over half
reported intravaginal cleansing after sex during
menstruation.
Discussion
In this study conducted in KwaZulu-Natal, South Africa,
we found that the majority of women did not report post-
coital intravaginal cleansing at any time during the
microbicide trial. However, one-third of women reported
doing so less than 1 h after sex, despite receiving coun-
selling not to do so. Post-coital intravaginal cleansing is
clearly an important practice for some women in terms of
managing their sexual health and sexuality [19]. None-
theless, our study suggests that this practice may be ame-
nable to change. Nearly half the women who said they
intravaginally cleansed during the first 6 months of the trial
did not do so during the second 6 months after repeated
counselling to refrain from intravaginally cleansing within
an hour after sex.
1 Shembe is based on the teachings of Isaiah Shembe (1867–1935), is
part of the Nazareth Baptist Churches and is the oldest African
Independent Church in South Africa, concentrated among Zulu
Footnote 1 continued
populations. Shembe promotes traditionalist Zulu values and beliefs,
such as polygamy, the role of the ancestors and the use of faith
healing.
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The prevalence of post-coital intravaginal cleansing was
higher in this community than previously reported in
KwaZulu-Natal [13]. In this population, younger age,
household crowding and increased sexual activity were
associated with post-coital intravaginal cleansing, although
condom use was not. Other studies in South Africa have
found age to be associated with intravaginal cleansing
generally, not just after sex [6, 7, 11]. In our study, women
over 45 years of age were least likely to report post-coital
intravaginal cleansing. In contrast to our findings, a
household survey among 18–60 year old women found
women aged 30–44 were significantly less likely to report
any type of intravaginal practice than women in younger
and older age groups [11]. The qualitative data did not help
explain why these practices differ by age. However, other
qualitative work in KwaZulu-Natal has suggested that
women increase intravaginal cleansing practices when they
are trying to attract a new partner, especially male partners
younger than themselves [38]. We did not collect data on
the age of partners and therefore were unable to test this
hypothesis.
The quantitative findings demonstrated that women in
larger households were more likely to cleanse intravagin-
ally after sex. The qualitative data offers a possible
explanation for this finding. Households in KwaZulu-Natal
are often patrilineal and multi-generational, and there were
frequent references to the need to be ‘clean’ before greeting
other people in the household as a sign of respect. In
contrast, household crowding was inversely associated
with intravaginal cleansing in Madagascar [39]. The
divergence of findings from South Africa and Madagascar
highlights the impact of socio-cultural influences on in-
travaginal practices and illustrates the need to consider the
impact of residential circumstances on intravaginal
cleansing practices in different societies. This is of par-
ticular interest given recent evidence that household size
also affects women’s use of microbicide gels in Uganda
[40].
In this analysis, the prevalence of post coital intrava-
ginal cleansing was higher among women who reported
having sex more often. Other studies in Southern Africa
have found an association between intravaginal cleansing
and sexual activity [6, 7, 11, 39]. Our analysis is unusual in
measuring the impact of sexual frequency on post-coital
intravaginal cleansing among sexually active women who
are not engaged in commercial sex work. The qualitative
data also suggests a relationship between intravaginal
cleansing and sexual frequency as some women purpose-
fully cleansed intravaginally to remove the old gel in
preparation to insert the new gel for the next act of sex.
This finding regarding the association with sexual activity
could have particular implications for microbicide dosing
strategies that require peri-coital insertion.
Other studies in South Africa have found that intrava-
ginal practices, although not specifically post-coital in-
travaginal cleansing, are reported less by women who use
condoms [6, 9, 11, 41]. Van der Straten suggests that ‘‘the
use of male condoms should prevent any post-coital dis-
charge, and hence, this may in part explain lower vaginal
practices’’ [42, p 597]. In contrast, our findings demon-
strate that intravaginal cleansing is influenced equally by
the need to remove vaginal sexual fluids and sweat, as well
as semen. This is supported by substantial evidence that
people define both semen and post-coital vaginal secretions
as smelly, dirty and polluting in many parts of Africa [13,
22, 43–47].
The qualitative data suggests that intravaginal cleansing
mainly involves water, fingers and/or a cloth. These forms
of intravaginal cleansing have been dominant in previous
studies [6, 11, 13, 22, 43, 48–55]. Unlike reports from other
studies in KwaZulu-Natal [13], there were few reports in
this analysis of commercial or other products being used
for intravaginal cleansing. However, this is still cause for
concern as intravaginal use of cloth or paper, as well as
intravaginal cleansing with soap, and intravaginal insertion
of products to dry or tighten the vagina, is associated with a
significant increased risk of HIV acquisition [56].
A number of issues emerged during the analyses that
require further attention in future studies. Firstly, it is of
particular interest that intravaginal cleansing was more
common among consistent compared to inconsistent gel
users. The fact that we measured post-coital intravaginal
cleansing during a year of follow-up, may explain why we
recorded higher prevalence than the WHO survey in
KwaZulu-Natal [13]. However, we cannot rule out the
possibility that the use of gel influenced intravaginal
cleansing. In another study where intravaginal cleansing
was associated with using HEC placebo gel, compared to
the less viscous Acidform gel, the authors concluded that:
‘‘gels may have been sensed as moisture or wetness, … as
more gel accumulated in the vagina, women may have
experienced a greater compulsion to cleanse despite having
been instructed not to do so’’ [39, p 193]. In contrast a
diaphragm trial found that in the intervention arm, women
who intravaginally cleansed were less likely to report
consistent use of a lubricant gel when administered in a
diaphragm [9]. However, the authors attributed this more to
the diaphragm than the presence of the gel, which has been
shown elsewhere [10, 57]. In this analysis post coital in-
travaginal cleansing did not differ by gel group, although
collectively these findings highlight the need to continue
measuring intravaginal cleansing in relation to new mi-
crobicides formulations. While we measured the proportion
of women who ever reported post-coital intravaginal
cleansing, we did not calculate the frequency with which
women cleansed. We plan to conduct a frequency analysis
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using the entire MDP 301 dataset which will be important
in terms of considering the implications of post-coital in-
travaginal cleansing on the ability of trials to measure
microbicide effectiveness.
Evidence from MDP 301 and other microbicide trials
has shown that many women describe microbicides as
being cleansing and hygienic [58–61]. Our findings dem-
onstrate that we need to understand more about women’s
perception of microbicides and their cleansing properties,
as well as exploring the broader implications of this rela-
tionship between using vaginal microbicides and post-
coital intravaginal cleansing. The suggestion that product
use (microbicide or diaphragm) influences intravaginal
cleansing practices, or vice versa, is critically important for
the future of HIV prevention and requires far more focused
attention in future research.
The second issue relates to intravaginal cleansing after
sex during menstruation. Despite cultural taboos sur-
rounding sex during menstruation [45], both the quantita-
tive and qualitative findings confirm that a minority of
women do have sex during menstruation in this commu-
nity. In the quantitative analysis, ‘ever’ having sex during
menstruation was not associated with intravaginal cleans-
ing after sex, although we were unable to measure intrav-
aginal cleansing specifically after sex during menstruation.
Collectively the quantitative and qualitative analyses show
that some women have sex during menstruation and use gel
when having sex during menstruation. The qualitative
findings suggest that during menstruation women may be
more inclined to cleanse intravaginally after sex. Increased
intravaginal cleansing during menstruation is well docu-
mented [13, 22, 41, 62]. However, there has been little
attention to intravaginal cleansing specifically in relation to
sex during menstruation. These findings highlight the need
to understand more about sex during menstruation, gel use
at time of sex during menstruation and intravaginal
cleansing after sex during menstruation.
The third issue relates to behaviour change. Although
the prevalence of intravaginal cleansing up to an hour after
sex in this study was not optimal for microbicide use, it
does appear from both the quantitative and qualitative data
that some women were willing to stop intravaginal
cleansing when using microbicides. The fact that some
women misunderstood the messaging and assumed they
should remove the gel after sex, illustrates the need for
consistent counselling regarding intravaginal cleansing.
Similarly, the fact that intravaginal cleansing practices
differed between clinics, but not by area of residence, and
declined over time differentially by clinic, suggests that the
differences may relate to counselling messages. Counsel-
ling has been shown to decrease intravaginal practices
among women in other microbicide and diaphragm trials,
although in some studies this has had a bigger impact on
reducing intravaginal insertion than cleansing [9, 29, 39,
63]. Counselling has been used successfully in the USA to
bring about a reduction in intravaginal cleansing [64].
Counselling messages regarding the use of microbicides
and intravaginal cleansing need to be developed and
evaluated, and we need to ensure that the decrease in
cleansing observed in this study was not an artefact of post-
coital intravaginal cleansing merely being practiced
inconsistently and in response to specific circumstances.
The main strength of this analysis is that it is the first to
measure intravaginal cleansing less than 1 h after sex,
which is the period of greatest relevance for microbicide
gel use. However, one limitation of the quantitative ana-
lysis is that we rely solely on self-reported intravaginal
cleansing data from the administered questionnaires. A
previous study found that, compared to administered
questionnaires, pictorial daily self-completed diaries can
improve the accuracy of data on cleansing frequency and
cleansing in proximity to sex [65, 66]. Interestingly, a study
in Tanzania found that a higher proportion of women
reported vaginal washing (although not specifically in-
travaginal cleansing) in face-to-face interviews compared
with coital diaries, suggesting a social desirability bias
towards over reporting washing practices [66]. We cannot
rule out the fact that IVC was over or under-reported in this
analysis, although the fact that the quantitative data are
remarkably consistent with the qualitative IDI data,
increases confidence in the estimated prevalence of post-
coital intravaginal cleansing in this cohort. Other limita-
tions of these analyses are that we did not explore why
women stopped intravaginal cleansing and what impact
this had on their overall vaginal hygiene practices, and
whether women who continued post-coital intravaginal
cleansing understood that this could potentially limit the
effectiveness of a microbicide gel. Given no-one in this
study reported the use of douching devices, we also missed
an opportunity to explore the exact mechanisms by which
women intravaginally cleansed with water alone.
We did not find any associations between intravaginal
cleansing and educational level, employment type, con-
traceptive use, or HIV/STI prevalence, as has been
observed in other studies in South Africa [6, 7, 11, 13, 39].
However, it is a limitation of this study that we were not
able to test other factors that have been shown to be
associated with intravaginal practices, including marital
status, religiosity, concern about STIs, concern about
partner’s fidelity, and access to media [6, 7, 11, 13].
Conclusion
Although the majority of women in the Africa Centre MDP
301 microbicide trial in KwaZulu-Natal did not report
AIDS Behav (2014) 18:297–310 307
123
intravaginal cleansing less than 1 h after sex, about one-
third of women did report this practice despite repeated
counselling to the contrary. Nonetheless, the analysis
suggests that this practice may be amenable to change. In
order to develop effective messages and counselling prac-
tices, it is vital that we understand more about the impact of
post-coital intravaginal cleansing on product efficacy and
explore further the association between gel use and post-
coital intravaginal cleansing. If post-coital intravaginal
cleansing significantly reduces the efficacy of microbi-
cides, whether delivered before or after sex or in a vaginal
ring, then cleansing practices could undermine the efficacy
of microbicides for some women in the absence of effec-
tive behaviour change programmes.
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